Altcoins News
By Maheen Hernandez
1 / 15
Stock Price Surge Follows Treasury. On Monday, Sharps shares surged to an intraday high of $14.
2 / 15
Details of the $400M Solana Treasury Strategy. Sharps confirmed that it signed a letter of intent with the Solana Foundation to purchase $50…
3 / 15
New Leadership to Drive the Crypto Pivot. To spearhead its digital treasury strategy, Sharps appointed Alice Zhang, co-founder of Web3…
4 / 15
Why Solana?. Solana has emerged as one of the most institutionally supported blockchains in 2025.
5 / 15
Healthcare Firms Joining the Crypto Treasury Trend. Sharps’ pivot isn’t happening in isolation. Several healthcare and biotech firms have recently…
6 / 15
Wall Street Voices Caution. Despite investor enthusiasm, analysts are cautious. In a recent educational video, Charles Schwab…
7 / 15
Institutional Support Could Mitigate Risks. Sharps’ strategy also benefits from growing institutional adoption of Solana.
8 / 15
Looking Ahead. The offering is expected to close on or around August 28, with accredited investors funding…
9 / 15
Medical device manufacturer Sharps Technology (NASDAQ: STSS) stunned investors this week after revealing a bold pivot into digital assets.
10 / 15
On Monday, Sharps shares surged to an intraday high of $14.53, nearly doubling from Friday’s close of $7.40. The stock later settled at $12.
11 / 15
The rally was fueled by Sharps’ reveal of a private placement deal and a new partnership with the Solana Foundation to acquire SOL, the blockchain’s native token.
12 / 15
Sharps confirmed that it signed a letter of intent with the Solana Foundation to purchase $50 million worth of SOL tokens through a private investment in public equity (PIPE)…
13 / 15
Accredited investors will buy company stock bundled with stapled warrants at $6.50 per unit.
14 / 15
Warrants will be exercisable at $9.75 over three years.
15 / 15
The equity offering directly links Sharps’ performance to Solana’s token price trajectory.
The Currency Analytics
Want the full story?